Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 25
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Radiotherapy, Cetuximab, and Injections of TNFeradeā¢ Biologic for Elderly or Frail Patients With Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
Over 18
Pharmaceutical / Industry
UCIRB #14735B
GV-001.010 (TNF-ELF), NCT00496236
Last Modified:
10/21/2008
 
First Published:
6/23/2003
2.
Phase II Randomized Study of Fruit and Vegetable Extracts in Patients With Stage I-IVB Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
CCCWFU-0112
CCCWFU-60A02, CCCWFU-BG03-161, NCT00064298
3.
Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
06U.195
NCT00358007
First Published:
3/22/2007
4.
Phase II Study of Photodynamic Therapy With Porfimer Sodium in Patients With Pre-Malignant or Malignant Lesions or Condemned Mucosa Syndrome in the Upper Aerodigestive Tract
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Over 18
Other
SCCC-2002103
SCCC-02/618C, SCCC-20050715, SCCC-20020618, NCT00453336
5.
Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
2006-0940
NCT00494182
6.
UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
19 and over
Other
F070824015
UAB 0718, NCT00570232
7.
Phase II Trial Evaluating Elimination of Radiation Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Over 18
Other
07-0142
NCT00593840
8.
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
08-050
NCT00713219
9.
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
05C.255
NCT00329589
Last Modified:
11/30/2006
 
First Published:
11/22/2006
10.
Phase I Randomized Pilot Study of Adjuvant Mutant p53 Peptide-Pulsed Dendritic Cell Vaccine With or Without T-Helper Peptides in Patients With Squamous Cell Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Over 18
NCI
PCI-03-156
PCI-0507062, NCT00404339
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute